Return On Equity of Day One Biopharmaceuticals, Inc. from 31 Dec 2020 to 31 Dec 2025

Taxonomy & unit: ratio: %
Description: Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary: Day One Biopharmaceuticals, Inc. quarterly and annual Return On Equity in % history and change rate from 31 Dec 2020 to 31 Dec 2025.
Day One Biopharmaceuticals, Inc. Return On Equity for the quarter ending 31 Dec 2025 was -23%, a 1.9% decline year-over-year.
Day One Biopharmaceuticals, Inc. annual Return On Equity for 2025 was -23%, a 1.9% decline from 2024.
Day One Biopharmaceuticals, Inc. annual Return On Equity for 2024 was -23%, a 56% increase from 2023.
Day One Biopharmaceuticals, Inc. annual Return On Equity for 2023 was -52%, a 22% decline from 2022.

Return On Equity, Quarterly (%)

Return On Equity, YoY Quarterly Change (%)

Return On Equity, Annual (%)

Return On Equity, YoY Annual Change (%)

Day One Biopharmaceuticals, Inc. Quarterly Return On Equity (%)

Period	Value	YoY Chg	Change %	Start Date	End Date
Q4 2025	-23%	-0.44%	-1.9%	01 Oct 2025	31 Dec 2025
Q3 2025	-32%	-9.7%	-43%	01 Jul 2025	30 Sep 2025
Q2 2025	-19%	+31%	+62%	01 Apr 2025	30 Jun 2025
Q1 2025	-15%	+42%	+74%	01 Jan 2025	31 Mar 2025
Q4 2024	-23%	+29%	+56%	01 Oct 2024	31 Dec 2024
Q3 2024	-22%			01 Jul 2024	30 Sep 2024
Q2 2024	-50%			01 Apr 2024	30 Jun 2024
Q1 2024	-57%			01 Jan 2024	31 Mar 2024
Q4 2023	-52%			01 Oct 2023	31 Dec 2023

Period	Value	YoY Chg	Change %	Start Date	End Date
2025	-23%	-0.44%	-1.9%	01 Jan 2025	31 Dec 2025
2024	-23%	+29%	+56%	01 Jan 2024	31 Dec 2024
2023	-52%	-9.4%	-22%	01 Jan 2023	31 Dec 2023
2022	-42%			01 Jan 2022	31 Dec 2022
2020	167%			01 Jan 2020	31 Dec 2020

* An asterisk sign (*) next to the value indicates that the value is likely invalid.